<SEC-DOCUMENT>0001104659-23-053379.txt : 20230706
<SEC-HEADER>0001104659-23-053379.hdr.sgml : 20230706
<ACCEPTANCE-DATETIME>20230501061051
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-23-053379
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Priveterra Acquisition Corp.
		CENTRAL INDEX KEY:			0001837607
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				853940478
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		300 SE 2ND STREET
		STREET 2:		SUITE 600
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33301
		BUSINESS PHONE:		(407) 808-1335

	MAIL ADDRESS:	
		STREET 1:		300 SE 2ND STREET
		STREET 2:		SUITE 600
		CITY:			FORT LAUDERDALE
		STATE:			FL
		ZIP:			33301
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0.05in; font-size: 10pt; width: 20%"><IMG SRC="tm2229000d16_correspimg01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0.05in; width: 24%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">W. Soren Kreider IV</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 212 450 4387</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">w.soren.kreider@davispolk.com</P></TD>
    <TD STYLE="width: 25%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Davis Polk &amp; Wardwell <FONT STYLE="font-variant: small-caps">llp</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">450 Lexington Avenue<BR>
    New York, NY 10017</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">davispolk.com&nbsp;</P></TD>
    <TD STYLE="padding-bottom: 0.05in; text-align: right; font-size: 10pt; text-transform: uppercase; width: 31%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 24.45pt">Re:</TD><TD>Priveterra Acquisition Corp.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 0pt">Registration Statement
on Form S-4 Amendment No. 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 0pt">Filed March 10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-indent: 0pt">File No. 333-269006</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 97%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONFIDENTIAL</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Life Sciences</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E., Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.8pt; text-indent: -42.8pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1.25in">Attention:&nbsp;</TD>
  <TD>Tracie Mariner, Kevin Vaughn, Cindy Polynice and Joe McCann</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.8pt; text-indent: -36.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ms. Mariner, Mr. Vaughn, Ms. Polynice and Mr. McCann:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On behalf of our client, Priveterra Acquisition Corp. (the &ldquo;<U>Company</U>&rdquo;),
this letter sets forth the Company&rsquo;s response to the comments provided by the Staff (the &ldquo;<U>Staff</U>&rdquo;) of the Division
of Corporation Finance of the U.S. Securities and Exchange Commission in your letter dated March 23, 2023 (the &ldquo;<U>Comment Letter</U>&rdquo;),
relating to the Company&rsquo;s registration statement on Form S-4 Amendment No. 2 (the &ldquo;<U>Registration Statement Amendment 2</U>&rdquo;),
filed on March 10, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has updated the Registration Statement Amendment 2 and
is filing a further amended registration statement on Form S-4 (the &ldquo;<U>Registration Statement Amendment 3</U>&rdquo;) together
with this response letter. The Registration Statement 3 also contains certain additional updates and revisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16.95pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 16.95pt 0pt 0">For the convenience of the Staff, each comment from the
Comment Letter is restated in italics prior to the Company&rsquo;s response to such comment. All references to page numbers and captions
in the Staff&rsquo;s comments correspond to pages and captions in the Registration Statement Amendment 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.5pt; text-indent: -24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.5pt; text-indent: -24.5pt"><I><U>Amendment No. 2 on Form S-4
filed March 10, 2023</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.5pt; text-indent: -24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Financial Statements of Priveterra Acquisition Corp.</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I><U>Note 6. Commitments and Contingencies, page F-17</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>1.</I></FONT></TD><TD><I>You disclose here that in November 2022 you recognized a gain of $3,767,400 in relation to the waiver of the deferred underwriter
fee allocated to the underwriter in the accompanying consolidated financial statements. You also disclose that an additional deferred
fee of $4,636,800 was waived on January 23, 2023. Your disclosures on page F-11 appear to indicate that your deferred underwriting costs
were originally charged to temporary equity or the consolidated statement of operations based on the relative value of the Public warrants.
Please address the following regarding the waiver of these deferred underwriting fees: </I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Tell us how you determined that reporting the waiver of these fees as a gain on your statement of operations is appropriate. Identify
the guidance on which you relied.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Tell how you determined that some or all of the waived fees should be reported as an adjustment to equity rather than a gain.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Tell us the extent to which the deferred underwriting fees that were subsequently waived were originally recorded as equity or
on your statement of operations.</I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><I>Tell us how you considered the guidance of ASC 420-10-40-1 in your determination of how to account for and report the waiver of
these fees.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Response: The Company respectfully acknowledges the Staff&rsquo;s comments
and has revised the disclosure on pages F-1 through F-15, F-21, F-25, and F-26 of the Registration Statement Amendment 3. Additionally, the Company amended their Form 10-K
with Amendment No. 1 which was filed on April 5, 2023.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0.05in; width: 20%">&nbsp;<IMG SRC="tm2229000d16_correspimg01.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 0.05in; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    Securities and Exchange Commission </FONT></TD>
    <TD STYLE="padding-bottom: 0.05in; width: 25%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0.05in; text-align: right; text-transform: uppercase; width: 30%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 &nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please do not hesitate to contact the undersigned if you have any questions
regarding the foregoing or if we may provide any additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-bottom: Black 1pt solid; width: 50%">/s/ W. Soren Kreider IV</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">W. Soren Kreider IV</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 30.6pt">cc:</TD><TD>Oleg Grodnensky, Chief Operating Officer,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt">Priveterra Acquisition
Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt">Lee Hochbaum, Davis Polk &amp; Wardwell
LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt">B. Shayne Kennedy, Latham &amp; Watkins
LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt">J. Ross McAloon, Latham &amp; Watkins
LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-top: Black 1pt solid; width: 50%">May 1, 2023</TD>
  <TD STYLE="border-top: Black 1pt solid; text-align: right; width: 50%">2</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt; text-indent: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2229000d16_correspimg01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2229000d16_correspimg01.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  > '@# 2(  A$! Q$!_\0
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M;?C2OP@'@P_!D_"%ADGX2?%3^W_^$B_X6EE7V:,-(;0@C)J0U;S=*\'^%_\
MP<4O\2/V^/V%OV'T_9!ETC_AM3]G']G_ /:"_P"%F-\?DU(?#I/CQ^S[<?'J
M7PO%X-/PFLSXKC\)8D\-MX@D\7^&7U)[.6:'PUHB&&)_XTO^"UO_  4LU_\
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M_P""@/[9/PP_X)B?M1?M%Z'\1_BQ^UYX&\/Z?_PI7X^:+X2U+PM\1?VD=/\
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MK\5_B#^WW\>/BQX?T[5-/\5V/A#7/%.C_L0>&O#7@F'7M-ABT74WT?P/X/\
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
